Healthcare Compliance

VA Notice of Information Collection Revision

The Department of Veterans Affairs (VA) is seeking public comment on a revision to an existing information collection related to property sales. This includes forms for offers to purchase, credit statements, and addenda, along with nine new forms, impacting individuals and households involved in VA property transactions.

AMA Statement Praises Court Ruling Blocking HHS Vaccine Policy Changes

The AMA issued a statement praising a court ruling blocking HHS vaccine policy changes, calling it 'an important step toward protecting the health of Americans, particularly children.' The AMA, which joined an amicus brief in the case of AAP v. Kennedy, reaffirmed its commitment to maintaining access to vaccines and ensuring immunization recommendations remain grounded in medical evidence. The statement emphasizes that vaccines are among the safest and most effective tools in medicine.

Virginia Health Department Announces Closures and Early Closures for March 16, 2026

The Virginia Department of Health announced closures and early closures for Monday, March 16, 2026. As of 1:55 p.m., six health departments were fully closed (Alexandria, Charles City, Essex County, Prince George, Surry, and Teen Wellness Center), while approximately 70 additional locations operated on early closure schedules ranging from 11:00 a.m. to 2:00 p.m. The closures represent routine administrative adjustments for weather or operational conditions.

Hampton & Peninsula Health Districts Partner with Virginia Peninsula Regional Jail on Health Literacy

The Hampton & Peninsula Health Districts (HPHD) and the Virginia Peninsula Regional Jail (VPRJ) formalized a partnership in June 2025 to deliver an eight-week health literacy education program to incarcerated individuals through the jail's "We Are All In This Together" (WAITT) program. The course covers 17 topics including nutrition, medication management, health insurance navigation, opioid overdose recognition, and workforce development. Since the partnership began, 88 jailed individuals have completed the program, and graduates have accessed substance use recovery services and other community health resources upon release.

FDA Acknowledgment Letter to Audio Source, Inc

The FDA has issued an acknowledgment letter to Audio Source, Inc. regarding a submission. This notice confirms receipt of the document by the agency.

FDA Complaint Document

The FDA has posted a complaint document related to its activities, with the comment period closing on March 16, 2026. The document is available for public review and input.

FDA Guidance on Progestins as Endocrine Disruptors

The FDA has issued new guidance concerning progestins and their potential role as endocrine disruptors. This document outlines the agency's current thinking and provides information relevant to manufacturers and public health authorities.

FDA Variance Amendment from J.M.W. Entertainment Group

The FDA has posted a variance amendment from J.M.W. Entertainment Group, LLC. The document was made available on March 16, 2026, via the Regs.gov portal. No further details on the amendment's content are provided.

FDA Study on Contraceptives, Herpes, and HIV Risk

The FDA has posted a study concerning the relationship between contraceptives, herpes, and HIV risk. The study details are available through the agency's regulatory portal.

FDA Glucocorticoid Receptor Gene Expression Study

The FDA has posted a study concerning Glucocorticoid Receptor gene expression. This notice is for informational purposes and does not introduce new regulatory requirements.

FDA Document on Contraceptive Status Among Females 15-49

The Food and Drug Administration (FDA) has issued a document concerning contraceptive status among females aged 15-49. This notice provides information on the topic without introducing new regulatory requirements.

FDA Complaint Document Details

The FDA has posted details regarding a complaint document, with the information made available on March 16, 2026. The document is related to a complaint filed with the agency.

FDA Study on Oral Contraception and HIV Risk in Africa

The FDA has published a notice regarding a study on the relationship between oral contraception and HIV risk in Africa. This notice is associated with docket number FDA-2026-P-2641-0031.

FDA Acknowledgment Letter to J.M.W. Entertainment Group

The FDA issued an acknowledgment letter to The J.M.W. Entertainment Group, LLC, regarding a submission. This notice confirms receipt of documentation by the FDA's Center for Devices and Radiological Health (CDRH).

FDA Complaint Document Posted

The FDA has posted a complaint document related to its regulatory activities. The document was made available on March 16, 2026, and was open for public comment. No specific details about the complaint's content or the nature of the comment period are provided.

FDA Variance Application from Audio Source, Inc

The FDA has posted a variance application from Audio Source, Inc. This document is available for review on the Regs.gov platform. The application pertains to medical device regulations.

FDA Complaint Posted for Public Comment

The FDA has posted a complaint for public comment, with the comment period closing on March 16, 2026. This action allows for public input on a specific complaint filed with the agency.

FDA Variance Application from J.M.W. Entertainment Group

The FDA has posted a variance application from The J.M.W. Entertainment Group, LLC. This document is available for review on the Regs.gov platform. No further details on the nature of the variance or its implications are provided in the notice.

FDA Progestins Classification and Pharmacology

The Food and Drug Administration (FDA) has published a document detailing the classification and pharmacology of progestins. This guidance provides information for manufacturers and pharmaceutical companies regarding these substances.

Hormonal Contraceptive Eligibility for Women at High HIV Risk

The FDA has issued draft guidance regarding the eligibility of hormonal contraceptives for women at high risk of HIV. This guidance aims to clarify recommendations and ensure appropriate access to contraceptive methods while considering HIV prevention strategies.

FDA Background Material on Contraceptive Use and HIV-1 Transmission Risk

The FDA has posted background material concerning contraceptive use and the risk of HIV-1 transmission. This notice provides scientific information relevant to public health discussions and regulatory considerations.

VA Celebrates Health Professions Education Week 2026

VA celebrates Health Professions Education (HPE) Week 2026, recognizing the role of trainees, academic partners, and education staff in developing the next generation of healthcare professionals to serve Veterans and the nation. More than 124,000 health professions trainees—including nursing and medical students, residents, and fellows—train at 142 VA medical centers through partnerships with over 1,500 academic institutions, comprising approximately one-third of VA's clinical workforce. Approximately 50% of all U.S. physicians have trained with VA at some point in their careers.

Gateway Health Plan Medicare Advantage Diagnosis Code Compliance Audit

HHS OIG completed a compliance audit of Gateway Health Plan's Medicare Advantage diagnosis codes submitted to CMS for risk adjustment. The audit found that 232 of 286 sampled enrollee-years (81%) lacked medical record support, resulting in $830,334 in net overpayments for the sample period. Based on statistical extrapolation, OIG estimated at least $4.3 million in total net overpayments for 2018–2019, recommending that Gateway refund the federal government, identify similar errors after the audit period, and strengthen its compliance procedures.

FDA Mammography Standards Quality Act Requirements Comment Request

The FDA has submitted a proposed collection of information related to Mammography Quality Standards Act requirements to the Office of Management and Budget (OMB) for review. The agency is requesting public comments on this information collection, with a deadline of April 13, 2026.

FDA Variance Approval for North Bay Productions

The FDA has issued a variance approval letter to North Bay Productions. This document, originating from the CDRH, signifies an approval related to a specific variance request.

FDA Variance Application from William Moore - Public Comment

The FDA is accepting public comments on a variance application submitted by William Moore. The comment period is open until March 13. This action pertains to a specific application for a variance.

FDA Variance Application from Low Frequency Productions

The FDA is accepting comments on a variance application submitted by Low Frequency Productions. This application pertains to medical device regulations. The comment period for this application closed on March 13.

VA Reaches Lifesaving Naloxone Availability Milestones

VA has expanded naloxone, a lifesaving opioid overdose antidote, to all 1,364 VA healthcare facilities and over 300 Vet Centers nationwide, reaching 6,852 high-risk locations. The initiative, which has distributed naloxone to more than 766,800 VA patients and documented over 7,200 successful overdose reversals, aligns with CDC data showing a 44% reduction in opioid overdose deaths for the 12-month period ending August 2025 compared to 2023. In February 2026, VA surpassed 2 million naloxone prescriptions dispensed to patients.

VA Application for Child Disabilities Benefits Notice

The Department of Veterans Affairs (VA) has issued a notice regarding a revision to VA Form 21-0304, Application for Benefits for Qualifying Veteran's Child Born With Disabilities. This revision is part of a routine Paperwork Reduction Act submission to OMB and does not include substantive changes to the form itself, though respondent burden has slightly increased.

VA Notice on Training Hours Certification Collection

The Department of Veterans Affairs (VA) is seeking public comment on a proposed revision to the collection of information for VA Form 28-1905c, concerning the certification of training hours, wages, and progress for vocational rehabilitation programs. The comment period closes on May 12, 2026.

VA Notice on Loan Account Foreclosure Information Collection

The Department of Veterans Affairs (VA) is seeking public comment on the proposed collection of information related to VA Form 26-0971, Status of Loan Account—Foreclosure or Other Liquidation. This notice is part of the process for extending an existing information collection under the Paperwork Reduction Act.

VA Seeks Public Comment on GSE Industry Appraisal Report Collection

The Department of Veterans Affairs (VA) is seeking public comment on a proposed revision to its Government-Sponsored Enterprise (GSE) Industry Appraisal Report information collection. This revision is a technical renaming of existing appraisal forms and does not alter the information collected or the estimated burden.

VA Notice on Loan Assumption Collection Activity

The Department of Veterans Affairs (VA) is seeking public comment on a proposed revision to VA Form 26-6382, used for loan assumption eligibility. The agency estimates an increase in annual burden hours due to higher usage of assumable VA loans.

WIC Breastfeeding Award of Excellence Notice - Public Comment Period

The Food and Nutrition Service (FNS) is seeking public comment on a proposed revision to an information collection regarding the WIC Breastfeeding Award of Excellence. This award recognizes local WIC agencies for their breastfeeding promotion and support activities. The comment period closes on May 11, 2026.

SNAP Interstate Data Matching for Preventing Multiple Issuances

The Food and Nutrition Service (FNS) is seeking public comment on a proposed revision to an information collection request concerning the Supplemental Nutrition Assistance Program (SNAP) National Accuracy Clearinghouse (NAC). This revision updates the estimated burden for state agencies to implement interstate data matching to prevent duplicate benefit issuances.

SNAP Trafficking Controls and Fraud Investigations Notice

The Food and Nutrition Service (FNS) has issued a notice regarding a revision to an information collection concerning Supplemental Nutrition Assistance Program (SNAP) Electronic Benefit Transfer (EBT) card replacements and fraud investigations. The public is invited to comment on the proposed changes.

OSHA Expands Recognition for Bay Area Compliance Laboratories

OSHA has issued a final notice announcing the expansion of the scope of recognition for Bay Area Compliance Laboratories (BACL) as a Nationally Recognized Testing Laboratory (NRTL). This expansion adds three test standards to BACL's recognized scope, effective March 11, 2026.

OSHA Expands Recognition for TUV Rheinland of North America

OSHA has issued a final notice expanding the scope of recognition for TUV Rheinland of North America, Inc. (TUVRNA) as a Nationally Recognized Testing Laboratory (NRTL). This expansion adds one test standard to TUVRNA's recognized capabilities, effective March 11, 2026.

OSHA Notice: DEKRA Certification Scope Expansion

OSHA has issued a notice announcing the final decision to expand the scope of recognition for DEKRA Certification Inc. as a Nationally Recognized Testing Laboratory (NRTL). This expansion includes the addition of nine test standards to DEKRA's recognized scope, effective March 11, 2026.

OSHA ACCSH Member Appointments and Meeting Notice

OSHA announces the appointment of nine members to the Advisory Committee on Construction Safety and Health (ACCSH) effective February 6, 2026. The notice also schedules the next ACCSH meeting for March 31 and April 1, 2026, and sets a comment deadline of March 20, 2026.

OSHA Notice: FM Approvals LLC Recognition Expansion

OSHA has issued a notice announcing the final decision to expand the scope of recognition for FM Approvals LLC as a Nationally Recognized Testing Laboratory (NRTL). This expansion includes adding one test standard to the NRTL Program's List of Appropriate Test Standards.

HHS Proposes Rescinding LGBTQI+ Children Placement Rule

The Administration for Children and Families (ACF) proposes to remove a final rule concerning designated placement requirements for LGBTQI+ children in foster care. This action follows a court decision vacating the rule, which the court found exceeded HHS's statutory authority. The public comment period for this proposed rescission ends April 6, 2026.

HHS Drug Testing Panel Guidelines

The Department of Health and Human Services (HHS) has issued updated guidelines for authorized drug testing panels used in federal workplace drug testing programs. The current drug testing panels for urine and oral fluid, along with the required nomenclature for laboratory and Medical Review Officer Reports, remain in effect as of July 7, 2025, with minor edits to footnotes for clarity.

Draft Labeling for Atomoxetine HCL Solution

The FDA has posted draft labeling for Atomoxetine HCL Solution for public comment. This document outlines proposed changes to the drug's labeling, which will impact manufacturers and potentially healthcare providers.

FDA Acknowledgment Letter to Athyna Pharma

The FDA's Center for Drug Evaluation and Research (CDER) has issued an acknowledgment letter to Athyna Pharma, LLC. This notice confirms receipt of a submission from the company.

FDA Approves Labeling for RS, ANDA 202682

The U.S. Food and Drug Administration (FDA) has approved labeling for RS, as indicated by ANDA 202682. This approval was posted on March 13, 2026, and pertains to specific drug product labeling.

FDA Acknowledgment Letter to Special FX Rentals

The FDA's Center for Devices and Radiological Health (CDRH) has issued an acknowledgment letter to Special FX Rentals. This notice confirms receipt of documentation and does not indicate approval or disapproval of any submissions.

FDA Document - Copyrighted Content

The FDA has posted a document containing copyrighted content, identified by the docket number FDA-2026-P-2640-0004. The content itself is restricted due to copyright. This notice serves to inform the public of the document's availability and its restricted nature.